血清白介素6及其可溶性受体水平与Graves眼病活动性

Relationship between serum concentrations of interleukin-6 (IL-6), soluble IL-6 receptor and the activity of Graves′ ophthalmopathy

测定Graves眼病 (GO)组 ,Graves病无眼病组 (NGO) ,正常对照组 3组血清白介素 6(IL 6)、可溶性IL 6受体 (sIL 6R)的水平和对GO组中激素治疗有效亚组与无效亚组间临床活动性评分 (CAS) ,结果显示血清IL 6、sIL

Serum concentrations of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) were determined in patients with Graves′ ophthalmopathy (GO), Graves′disease without GO (NGO) and controls. Patients with GO treated by corciosteroids were assessed by the clinical activity score (CAS). The results suggested that serum levels of both IL-6, sIL-6R and CAS could reflect the activity of GO and predict the outcome of corcicosteroid therapy.